MYC and colonic neoplasm: Our work suggests an interesting possibility that deregulated proteostasis with overstressed protein quality control is a druggable vulnerability of colon cancers driven by Wnt/Myc and mutant RAS/RAF [3], which predisposes to hyperactivation of ATF4/CHOP and catastrophic ER stress.